Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib Alternating with Chemotherapy in Metastatic Colorectal Cancer
NCT00642746Phase 2Terminated
- Sponsor
- OHSU Knight Cancer Institute
- Start
- Mar 2008
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in metastatic colorectal cancer (mCRC), sponsored by OHSU Knight Cancer Institute. Started Mar 2008; status: terminated.
02
Drugs
erlotinib
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00642746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00642746.